Global Intravenous Anesthetic Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Intravenous Anesthetic Market Research Report 2024
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
According to Mr Accuracy reports new survey, global Intravenous Anesthetic market is projected to reach US$ 5842.6 million in 2029, increasing from US$ 4470 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Anesthetic market research.
Key manufacturers engaged in the Intravenous Anesthetic industry include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intravenous Anesthetic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous Anesthetic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Anesthetic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Intravenous Anesthetic market is projected to reach US$ 5842.6 million in 2029, increasing from US$ 4470 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Anesthetic market research.
Key manufacturers engaged in the Intravenous Anesthetic industry include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intravenous Anesthetic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous Anesthetic market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Anesthetic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source